USP1 (G670A, G671A)/UAF1 Complex Recombinant

Catalog #
101667
$495 *
Size: 50 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human complex made of USP1 (ubiquitin specific peptidase 1), encompassing amino acids 2-785(end), and UAF1 (ubiquitin specific peptidase 1-associated factor 1), encompassing amino acids 1-677 (end). The USP1 construct contains an N-terminal FLAG-Tag and the UAF1 construct contains a C-terminal His-tag (6xHis). The proteins were co-expressed and purified as a complex. Two mutations of interest are present in USP1, G670A, G671A.

Synonyms
Deubiquitinating enzyme 1 (hUBP), Ubiquitin thioesterase 1, Ubiquitin-specific-processing protease 1, WDR48, WD repeat-containing protein 48, USP1-associated factor 1, KIAA1449, USP-1, UAF-1
Product Info
Storage and Usage
Citations
Species
Human
Construct
USP1 (FLAG-2-785(end)) / UAF1 (1-677(end)-His)
Mutation
USP1: G670A, G671A
Host Species/Expression System
HEK293
Purity

≥85%

Format

Aqueous buffer solution.

Formulation

40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 80 µg/ml FLAG peptide, and 20% glycerol

MW
USP1: 89 kDa; UAF1: 77 kDa
Amino Acids
USP1: 2-785(end); UAF1: 1-677(end)
Genbank #
USP1: NM_003368.4; UAF1: NM_020839.4
UniProt #
USP1: O94782; UAF1: Q8TAF3
Tag(s)
N-Terminal FLAG Tag, C-Terminal His-Tag
Background

Ubiquitin specific peptidase 1 (USP1) belongs to a large group of ubiquitin-specific proteases capable of cleaving ubiquitin from other proteins. These enzymes are also referred to as deubiquitinating peptidases, deubiquitinases (DUBs), ubiquitin proteases, ubiquitin hydrolases or ubiquitin isopeptidases. USP1 requires the presence of UAF1 (ubiquitin specific peptidase 1-associated factor 1) to be active, making UAF1 its regulator. DUBs contribute to the ubiquitin signaling pathway by countering the signal induced by ubiquitin conjugating enzymes and ligases. DUBs are a new therapeutic target for neurodegenerative diseases, cancer, diabetes, and autoimmune pathologies.